Erasmus University Medical Center based in Rotterdam, Netherlands, affiliated with Erasmus University and home to its faculty of medicine, is the 'largest and one of the most authoritative scientific University Medical Centers in Europe.'

There are 1,125 beds in Erasmus MC - Thoraxcenter.

During the past decade, Erasmus MC - Thoraxcenter conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erasmus MC - Thoraxcenter" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Cordis Corporation" with 2 trials sponsored, "Cytori Therapeutics" with 2 trials sponsored and "Air Liquide Santé International" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erasmus MC - Thoraxcenter" #1 collaborator was "Meditrial Europe Ltd." with 1 trials as a collaborator, "Medtronic - MITG" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator, "Thoratec Corporation" with 1 trials as a collaborator and "Thoratec Europe Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Erasmus MC - Thoraxcenter" are "Coronary Artery Disease" (6 trials), "Cardiovascular Disease" (3 trials), "Coronary Arteriosclerosis" (2 trials), "Coronary Disease" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Erasmus MC - Thoraxcenter" in a lesser frequency.

Most popular intervention types in "Erasmus MC - Thoraxcenter" are "Device" (12 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Confirm Rx ICM insertion procedure" (1 trials), "Covidien OneShot™ System" (1 trials), "Direct injection of ADRCs into the Left Ventricle" (1 trials), "Direct injection of placebo into the Left Ventricle" (1 trials) and "HeartMate 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erasmus MC - Thoraxcenter" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Erasmus MC - Thoraxcenter". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Erasmus MC - Thoraxcenter, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Erasmus MC - Thoraxcenter, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".